Description: The ability to substitute one drug product for another while maintaining equivalent clinical performance, or to change states in a discrete dynamical system.
1996 · Food and Drug Administration Individual Bioequivalence Working Group, Robert Schall, et al. · Journal of Pharmacokinetics and Biopharmaceutics · 66